Recent EVAX News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/10/2025 12:15:36 PM
- Evaxion to present at World Vaccine Congress • GlobeNewswire Inc. • 04/10/2025 12:00:38 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/07/2025 10:00:16 AM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/01/2025 01:33:57 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/01/2025 11:45:17 AM
- Evaxion announces business update and full year 2024 financial results • GlobeNewswire Inc. • 04/01/2025 11:30:35 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/27/2025 12:15:31 PM
- Evaxion to announce business update and full year 2024 financial results on April 1, 2025 • GlobeNewswire Inc. • 03/27/2025 12:00:21 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/26/2025 08:30:23 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/26/2025 08:01:53 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/25/2025 08:45:33 PM
- Evaxion to present new phase 2 data for AI-designed personalized cancer vaccine EVX-01 at AACR Annual Meeting • GlobeNewswire Inc. • 03/25/2025 08:30:39 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/25/2025 04:15:12 AM
- Form F-3 - Registration statement by foreign private issuers • Edgar (US Regulatory) • 03/13/2025 08:01:53 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/04/2025 01:15:19 PM
- Evaxion to present at numerous upcoming conferences • GlobeNewswire Inc. • 03/04/2025 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/25/2025 01:15:52 PM
- Evaxion extends phase 2 trial with personalized cancer vaccine EVX-01 to further enhance clinical data package • GlobeNewswire Inc. • 02/25/2025 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/14/2025 01:15:24 PM
- Nasdaq confirms Evaxion is fully compliant, withdraws delisting determination • GlobeNewswire Inc. • 02/14/2025 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/12/2025 01:00:59 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/31/2025 09:15:41 PM
- Evaxion announces closing of $10.8 million public offering • GlobeNewswire Inc. • 01/31/2025 09:05:00 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 01/31/2025 11:33:18 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/30/2025 01:05:47 PM
VAYK Corrects Major Clerical Error to Report $668K Operating Revenue for 2024 • VAYK • Apr 17, 2025 9:00 AM
UAV Corp Names David Dugas as President and Chief Operating Officer • UMAV • Apr 17, 2025 8:30 AM
Yuengling's Ice Cream Corporation (OTC: YCRM), Doing Business as ReachOut, Files 2024 10-K With Profitability, Growth, and Corporate Transformation in Focus • YCRM • Apr 16, 2025 11:07 AM
Avant Technologies and JV Partner, Ainnova, Accelerate Expansion Across Latin America Following Key Role at Healthcare Innovation Summit • AVAI • Apr 16, 2025 8:00 AM
HealthLynked Welcomes Anthony Scuilla as Sales Consultant to Drive Strategic Partnerships with Insurance Providers • HLYK • Apr 14, 2025 8:00 AM
Glidelogic Corp. Partners with Sunwah Global Youth Innovation Center • GDLG • Apr 10, 2025 4:00 PM